Olanzapine in the Treatment of Developmental Stuttering: A Double-Blind, Placebo-Controlled Trial

By MAGUIRE GERALD   RILEY GLYNDON   FRANKLIN DAVID   MAGUIRE MICHAEL   NGUYEN CHARLES   BROJENI PEDRAM  

Annals of Clinical Psychiatry (after Jan 1, 2004), Vol. 16, Iss. 2, 2004-01 ,pp. : 63-67

Informa Healthcare

Access to resources Recommend Favorite

Risperidone Improves Behavioral Symptoms in Children with Autism in a Randomized, Double-Blind, Placebo-Controlled Trial

By Pandina Gahan   Bossie Cynthia   Youssef Eriene   Zhu Young   Dunbar Fiona  

Journal of Autism and Developmental Disorders, Vol. 37, Iss. 2, 2007-02 ,pp. : 367-373

Springer Publishing Company

Access to resources Recommend Favorite

Second-Generation Antipsychotic Medications and Risk of Pneumonia in Schizophrenia

By Kuo Chian-Jue   Yang Shu-Yu   Liao Ya-Tang   Chen Wei J.   Lee Wen-Chung   Shau Wen-Yi   Chang Yao-Tung   Tsai Shang-Ying   Chen Chiao-Chicy  

Schizophrenia Bulletin, Vol. 39, Iss. 3, 2013-05 ,pp. : 648-657

Oxford University Press

Access to resources Recommend Favorite

mGlu2/3 Agonists - a New Approach to the Treatment of Schizophrenia: Results of a Randomized Double-Blind Trial

By Mosolov S.  

Neuroscience and Behavioral Physiology, Vol. 41, Iss. 6, 2011-07 ,pp. : 559-566

Springer Publishing Company

Access to resources Recommend Favorite

Buspirone Versus Methylphenidate in the Treatment of Attention Deficit Hyperactivity Disorder: A Double-Blind and Randomized Trial

By Davari-Ashtiani Rozita  

Child Psychiatry and Human Development, Vol. 41, Iss. 6, 2010-12 ,pp. : 641-648

Springer Publishing Company

Access to resources Recommend Favorite